title: Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage.
abstract: The vitamin D receptor knockout (VDR-KO) mouse presents with a skeletal phenotype typical for complete lack of genomic 1,25-dihydroxycholecalciferol effects. Our previous data from human colorectal tissue suggest that the steroid hormone and its receptor may have protective function against tumour progression. In order to investigate the relevance of the vitamin D system for pre-malignant site-directed changes in the colon, we characterized the amount and site-specific distribution of the VDR along the large intestine in wild-type (WT), heterozygote (HT) and KO mice. We also evaluated expression of proliferating cell nuclear antigen (PCNA), of cyclin D1 and the levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative stress. In colon ascendens, proliferative cells were dispersed all along the crypt and expression levels of all three markers were high in WT mice. A decrease of VDR expression did not affect expression significantly. In colon descendens, however, fewer proliferative cells were solely located in the lower third of the crypt, and an inverse relationship between VDR reduction, PCNA positivity and cyclin D1 expression was found in HT and KO mice. In parallel to enhanced proliferation a highly significant increase of 8-OHdG positivity occurred. Therefore, the sigmoid colon of VDR-KO mice, fed on an appropriate lactose/calcium-enriched diet to alleviate impaired calcium homeostasis-related phenotypic changes, is an excellent model for investigating induction and prevention of pre-malignant changes in one of the hotspots for human colorectal cancer incidence.
authors.affiliation: Department of Pathophysiology, University of Vienna Medical School, Vienna, Ludwig Boltzmann Institute for Aging Research, Vienna, Austria.
authors.forename: E
authors.initials: E
authors.lastname: Kallay
authors.forename: P
authors.initials: P
authors.lastname: Pietschmann
authors.forename: S
authors.initials: S
authors.lastname: Toyokuni
authors.forename: E
authors.initials: E
authors.lastname: Bajna
authors.forename: P
authors.initials: P
authors.lastname: Hahn
authors.forename: K
authors.initials: K
authors.lastname: Mazzucco
authors.forename: C
authors.initials: C
authors.lastname: Bieglmayer
authors.forename: S
authors.initials: S
authors.lastname: Kato
authors.forename: H S
authors.initials: HS
authors.lastname: Cross
mesh_terms: D000080242:8-Hydroxy-2'-Deoxyguanosine; D000818:Animals; D002118:Calcium / Q000097:blood; D003106:Colon / Q000378:metabolism* / Q000473:pathology*; D015179:Colorectal Neoplasms / Q000378:metabolism / Q000473:pathology; D019938:Cyclin D1 / Q000096:biosynthesis; D004249:DNA Damage; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000096:biosynthesis; D004195:Disease Models, Animal; D005260:Female; D006706:Homeostasis; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D011230:Precancerous Conditions / Q000378:metabolism / Q000473:pathology; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis; D018167:Receptors, Calcitriol / Q000235:genetics / Q000378:metabolism*
chemical_list: D018809:Proliferating Cell Nuclear Antigen; D018167:Receptors, Calcitriol; D019938:Cyclin D1; D000080242:8-Hydroxy-2'-Deoxyguanosine; D003849:Deoxyguanosine; D002118:Calcium